Skip to main content
Top
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Research

Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control

Authors: Justice Nonvignon, Genevieve Cecilia Aryeetey, Keziah L. Malm, Samuel Agyei Agyemang, Vivian N. A. Aubyn, Nana Yaw Peprah, Constance N. Bart-Plange, Moses Aikins

Published in: Malaria Journal | Issue 1/2016

Login to get access

Abstract

Background

Despite the significant gains made globally in reducing the burden of malaria, the disease remains a major public health challenge, especially in sub-Saharan Africa (SSA) including Ghana. There is a significant gap in financing malaria control globally. The private sector could become a significant source of financing malaria control. To get the private sector to appreciate the need to invest in malaria control, it is important to provide evidence of the economic burden of malaria on businesses. The objective of this study, therefore, was to estimate the economic burden on malaria on businesses in Ghana, so as to stimulate the sector’s investment in malaria control.

Methods

Data covering 2012–2014 were collected from 62 businesses sampled from Greater Accra, Ashanti and Western Regions of Ghana, which have the highest concentration of businesses in the country. Data on the cost of businesses’ spending on treatment and prevention of malaria in staff and their dependants as well as staff absenteeism due to malaria and expenditure on other health-related activities were collected. Views of business leaders on the effect of malaria on their businesses were also compiled. The analysis was extrapolated to cover 5828 businesses across the country.

Results

The results show that businesses in Ghana lost about US$6.58 million to malaria in 2014, 90 % of which were direct costs. A total of 3913 workdays were lost due to malaria in firms in the study sample during the period 2012–2014. Businesses in the study sample spent an average of 0.5 % of the annual corporate returns on treatment of malaria in employees and their dependants, 0.3 % on malaria prevention, and 0.5 % on other health-related corporate social responsibilities. Again business leaders affirmed that malaria affects their businesses’ efficiency, employee attendance and productivity and expenses. Finally, about 93 % of business leaders expressed the need private sector investment in malaria control.

Conclusions

The economic burden of malaria on businesses in Ghana cannot be underestimated. This, together with business leaders’ acknowledgement that it is important for private sector investment in malaria control, provides motivation for engagement of the private sector in financing malaria control activities.
Literature
1.
go back to reference WHO. World malaria report 2015. Geneva: World Health Organization; 2015. WHO. World malaria report 2015. Geneva: World Health Organization; 2015.
2.
go back to reference Ghana Health Service. National malaria control programme annual report 2014. Ghana: Ghana Health Service; 2014. Ghana Health Service. National malaria control programme annual report 2014. Ghana: Ghana Health Service; 2014.
3.
go back to reference WHO. World malaria report 2013. Geneva: World Health Organization; 2014. WHO. World malaria report 2013. Geneva: World Health Organization; 2014.
4.
go back to reference Dillon A, Friedman J, Serneels P. Experimental estimates of the impact of malaria treatment on agricultural worker productivity, labor supply and earnings. Washington, D.C.: International Food Policy Research Institute (IFPRI); 2010. Dillon A, Friedman J, Serneels P. Experimental estimates of the impact of malaria treatment on agricultural worker productivity, labor supply and earnings. Washington, D.C.: International Food Policy Research Institute (IFPRI); 2010.
5.
go back to reference Leighton C, Foster R. Economic impacts of malaria in Kenya and Nigeria. Health financing and sustainability project 6. Bethesda: Abt Associates; 1993. Leighton C, Foster R. Economic impacts of malaria in Kenya and Nigeria. Health financing and sustainability project 6. Bethesda: Abt Associates; 1993.
6.
go back to reference MOH. The burden of malaria in Uganda: why all should join hands in the fight against malaria MOH-MLA-12. Kampala: Ministry of Health; 2001. MOH. The burden of malaria in Uganda: why all should join hands in the fight against malaria MOH-MLA-12. Kampala: Ministry of Health; 2001.
7.
go back to reference Nabyonga OJ, Muthuri KJ, Azairwe R, Muheki ZC, Bataringaya WJ, Ogwal OP. Cost of malaria morbidity in Uganda. J Biol Agric Healthc. 2011;1:35–58. Nabyonga OJ, Muthuri KJ, Azairwe R, Muheki ZC, Bataringaya WJ, Ogwal OP. Cost of malaria morbidity in Uganda. J Biol Agric Healthc. 2011;1:35–58.
8.
go back to reference Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg. 2001;64(suppl 1):85–96.PubMed Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg. 2001;64(suppl 1):85–96.PubMed
9.
go back to reference McCarthy FD, Wolf H, Wu Y. The growth costs of malaria. Working Paper No. 7541. Cambridge: National Bureau of Economic Research (NBER); 2000. McCarthy FD, Wolf H, Wu Y. The growth costs of malaria. Working Paper No. 7541. Cambridge: National Bureau of Economic Research (NBER); 2000.
10.
go back to reference World Economic Forum. Business and malaria: a neglected threat?. Davos: Harvard School of Public Health; 2006. World Economic Forum. Business and malaria: a neglected threat?. Davos: Harvard School of Public Health; 2006.
12.
go back to reference RBM. Action and investment to defeat malaria 2016–2030. Geneva: Roll Back Malaria Partnership; 2015. RBM. Action and investment to defeat malaria 2016–2030. Geneva: Roll Back Malaria Partnership; 2015.
13.
go back to reference Medicines for Malaria Venture. From aspiration to action: what will it take to end malaria?. Geneva: World Health Organization; 2015. Medicines for Malaria Venture. From aspiration to action: what will it take to end malaria?. Geneva: World Health Organization; 2015.
15.
go back to reference Cutler D, Fung W, Kremer M, Singhal M, Vogl T. Early-life malaria exposure and adult outcomes: evidence from malaria eradication in India. Am Econ J Appl Econ. 2010;2:72–94.CrossRef Cutler D, Fung W, Kremer M, Singhal M, Vogl T. Early-life malaria exposure and adult outcomes: evidence from malaria eradication in India. Am Econ J Appl Econ. 2010;2:72–94.CrossRef
16.
go back to reference RBM. Business investing in malaria control: economic returns and a healthy workforce for Africa. Progress and impact series, Number 6. Geneva: World Health Organization; 2011. RBM. Business investing in malaria control: economic returns and a healthy workforce for Africa. Progress and impact series, Number 6. Geneva: World Health Organization; 2011.
17.
go back to reference Asante FA, Asenso-Okyere WK. Economic burden of malaria in Ghana. Accra: Institute of Statistical, Social and Economic Research (ISSER); 2003. Asante FA, Asenso-Okyere WK. Economic burden of malaria in Ghana. Accra: Institute of Statistical, Social and Economic Research (ISSER); 2003.
18.
go back to reference Abotsi AK. Cost burden of infant malaria treatment on households and health institutions in the upper east region. J Art Soc Sci. 2012;1:168–89. Abotsi AK. Cost burden of infant malaria treatment on households and health institutions in the upper east region. J Art Soc Sci. 2012;1:168–89.
19.
go back to reference Sicuri E, Vieta A, Lindner L, Constenla D, Sauboin C. The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya. Malar J. 2013;12:307.CrossRefPubMedPubMedCentral Sicuri E, Vieta A, Lindner L, Constenla D, Sauboin C. The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya. Malar J. 2013;12:307.CrossRefPubMedPubMedCentral
20.
go back to reference Anglo Gold Ashanti. Obuasi malaria control programme: a model for Africa. Accra: Anglo Gold Ashanti; 2007. Anglo Gold Ashanti. Obuasi malaria control programme: a model for Africa. Accra: Anglo Gold Ashanti; 2007.
21.
go back to reference MOH. Strategic plan for malaria control in Ghana: 2008–2015. Accra: Ministry of Health; 2008. MOH. Strategic plan for malaria control in Ghana: 2008–2015. Accra: Ministry of Health; 2008.
22.
go back to reference Ghana Statistical Service (GSS), Ghana Health Service (GHS), ICF International. Ghana demographic and health survey 2014. Rockville: GSS, GHS, and ICF International; 2015. Ghana Statistical Service (GSS), Ghana Health Service (GHS), ICF International. Ghana demographic and health survey 2014. Rockville: GSS, GHS, and ICF International; 2015.
23.
go back to reference Yerushalmi E, Hunt P, Hoorens S, Sauboin C, Smith R. The macro-economic impact of reducing malaria: an application of a dynamic general equilibrium modelling to Ghana. Value Health. 2012;15:A400.CrossRef Yerushalmi E, Hunt P, Hoorens S, Sauboin C, Smith R. The macro-economic impact of reducing malaria: an application of a dynamic general equilibrium modelling to Ghana. Value Health. 2012;15:A400.CrossRef
24.
go back to reference GSS. National accounts statistics: final 2012 GDP and revised 2013 GDP estimates. Accra: Ghana Statistical Service; 2014. GSS. National accounts statistics: final 2012 GDP and revised 2013 GDP estimates. Accra: Ghana Statistical Service; 2014.
Metadata
Title
Economic burden of malaria on businesses in Ghana: a case for private sector investment in malaria control
Authors
Justice Nonvignon
Genevieve Cecilia Aryeetey
Keziah L. Malm
Samuel Agyei Agyemang
Vivian N. A. Aubyn
Nana Yaw Peprah
Constance N. Bart-Plange
Moses Aikins
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1506-0

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.